Live Analysis: The State Street SPDR S&P Biotech ETF (XBI) is currently priced at $132.37, showing a decrease of 67 cents (-0.504%) from the previous close at $133.04. Trading volume is at $2.96 million, representing a 31.83% deviation from the average. Recent price movements indicate a slight decline, influenced by market dynamics and investor sentiment.
Performance Streak: XBI has experienced a three-day streak of price decline, with a total absolute change of $-4.94 (-3.6%). The streak began at $137.31, showcasing a negative momentum in recent trading sessions. Investors are closely monitoring the asset's performance to assess potential future trends.
Dividends: In terms of dividends, XBI offers a forward dividend yield of 1.23%. The dividend per share MRQ stands at 40.656 cents, reflecting a year-over-year decrease of -95.9618 cents. The trailing twelve months dividend per share is reported at 44.0505 cents, indicating the company's dividend distribution trends.
Investors are advised to track XBI's performance closely, considering the recent price streak and dividend metrics as part of their investment decision-making process.
Stay tuned for further updates on XBI's performance and market movements.